Organisatie
Hematologie
Huidige onderzoekers
1 - 10 of 18 results
- Fatema Afennas (Lid)
- Veerle Beckers (Lid)
- Charlotte Caron (Lid)
- Ludwine Antoinette Claeys (Lid)
- Ann De Becker (Lid)
- Nathan De Beule (Lid)
- Inke De Haes (Lid)
- Sylvia Faict (Lid)
- Karel Fostier (Lid)
- Kristin Jochmans (Lid)
Projecten
1 - 1 of 1
- Tumor karakterisatie en ziekteopvolging in multipel myeloom door (epi) genetische typering gebruik makend van liquid biopsiesVanaf1 nov 2021 → HedenFinanciering: FWO junior postdoctoraal mandaat
Publicaties
21 - 30 van 79
- Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.(2021)
Auteurs: Anke Delie, Anke Verlinden, Karolien Beel, Dries Deeren, Dominiek Mazure, Frédéric Baron, Dimitri Breems, Ann De Becker, Carlos Graux, P. Lewalle, et al.
Pagina's: 500-508 - Predictors of late initiation for prenatal care in a metropolitan region in Belgium. A cohort study(2015)
Auteurs: Maaike Fobelets, Katrien Beeckman, Annemarie Hoogewys, Mieke Embo, Ronald Buyl, Koen Putman
Pagina's: 648-654 - Dendritic Cells: The Tools for Cancer Treatment(2018)
Auteurs: Hanne Locy, Sarah Melhaoui, Sarah Maenhout, Kris Thielemans
Pagina's: 101-128 - Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors(2020)
Auteurs: Julia Katharina Schwarze, G Awada, Louise Cras, Jens Tijtgat, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, Bart Neyns
Pagina's: 1-16 - Intratumoral administration of CD1c (BDCA-1)+ and CD141 (BDCA-3)+ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients(2022)
Auteurs: Julia Katharina Schwarze, Jens Tijtgat, G Awada, Louise Cras, Angela Vasaturo, Christopher Bagnall, Ramses Forsyth, Inès Dufait, Sandra Tuyaerts, Ivan Van Riet, et al.
Pagina's: 1-13 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Auteurs: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pagina's: 20476-20489 - Combination therapy for a durable tumor rejection(2018)
Auteurs: Lukasz Bialkowski, Kris Thielemans, Joeri L Aerts
- The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers(2022)
Auteurs: Rong Fan, Nathan De Beule, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Ken Maes, K Breckpot, Kim De Veirman
- AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies(2019)
Auteurs: Siyang Yan, Niels Vandewalle, Nathan De Beule, Sylvia Faict, Ken Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Kim De Veirman
Pagina's: 1-17 - Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation(2018)
Auteurs: Willem Staels, Yannick Verdonck, Yves Heremans, Gunter Leuckx, Sofie De Groef, Carlo Heirman, Eelco De Koning, Conny Gysemans, Kris Thielemans, L Baeyens, et al.
Pagina's: 1804-1810